Celyad Company
Celyad is a provider of cell therapy treatments with an initial focus on cardiology and oncology.
Total Funding:
146096840
Headquarters:
Mont-saint-guibert, Brabant Wallon, Belgium
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Last Funding Date:
2021-12-03
Investors Number:
5
Founded Date:
2007-01-01
Industry:
CAR-T